Bone morbidity in pediatric acute lymphoblastic leukemia

키워드

참고문헌 (73)

1. 이재욱, "Prognostic factors and treatment of pediatric acute lymphoblastic leukemia", Clinical and Experimental Pediatrics, 60(5), pp.129~137 (2017), 대한소아청소년과학회
2. Inaba H, "Acute lymphoblastic leukaemia", Lancet, 381, pp.1943~1955 (2013)
3. Demidowicz E, "Outcome of pediatric acute lymphoblastic leukemia : sixty years of progress", Anticancer Res, 39, pp.5203~5207 (2019)
4. Sklar CA, "Hypothalamic-pituitary and growth disorders in survivors of childhood cancer : an Endocrine Society Clinical Practice Guideline", J Clin Endocrinol Metab, 103, pp.2761~2784 (2018)
5. Howard SC, "Endocrine complications in pediatric patients with acute lymphoblastic leukemia", Blood Rev, 16, pp.225~243 (2002)
6. Mostoufi-Moab S, "Skeletal morbidity in children and adolescents during and following cancer therapy", Horm Res Paediatr, 91, pp.137~151 (2019)
7. Kizilocak H, "Late effects of therapy in childhood acute lymphoblastic leukemia survivors", Turk J Haematol, 36, pp.1~11 (2019)
8. Simm PJ, "Consensus guidelines on the use of bisphosphonate therapy in children and adolescents", J Paediatr Child Health, 54, pp.223~233 (2018)
9. Mostoufi-Moab S, "Bone morbidity in childhood leukemia : epidemiology, mechanisms, diagnosis, and treatment", Curr Osteoporos Rep, 12, pp.300~312 (2014)
10. Warner JT, "Relative osteopenia after treatment for acute lymphoblastic leukemia", Pediatr Res, 45, pp.544~551 (1999)
11. Davies JH, "Skeletal morbidity in childhood acute lymphoblastic leukaemia", Clin Endocrinol(Oxf), 63, pp.1~9 (2005)
12. Shimo T, "Mechanism of cancer-induced bone destruction: an association of connective tissue growth factor (CTGF", CCN2) in the bone metastasis, 2011, pp.47, 13~22
13. Mattia C, "Bone pain mechanism in osteoporosis : a narrative review", Clin Cases Miner Bone Metab, 13, pp.97~100 (2016)
14. Natthapon Angsubhakorn, "Acute lymphoblastic leukaemia with osteolytic bone lesions: diagnostic dilemma", BMJ Case Reports, pp.bcr-2018-225008~ (2018), BMJ[DOI]
15. Shuhart CR, "Executive summary of the 2019 ISCD position development conference on monitoring treatment, dxa cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics", J Clin Densitom, 22, pp.453~471 (2019)
16. Cummings EA, "Incident vertebral fractures in children with leukemia during the four years following diagnosis", J Clin Endocrinol Metab, 100, pp.3408~3417 (2015)
17. Halton J, "Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program", J Bone Miner Res, 24, pp.1326~1334 (2009)
18. Carriere B, "Vertebral fractures as initial signs for acute lymphoblastic leukemia", Pediatr Emerg Care, 17, pp.258~261 (2001)
19. Stagi S, "Bone health in children and adolescents : the available imaging techniques", Clin Cases Miner Bone Metab, 10, pp.166~171 (2013)
20. Genant HK, "Vertebral fracture assessment using a semiquantitative technique", J Bone Miner Res, 8, pp.1137~1148 (1993)
21. Koerber F, "Introduction of a new standardized assessment score of spine morphology in osteogenesis imperfecta", Rofo, 184, pp.719~725 (2012)
22. Kim YM, "Intra-and inter-reader reliability of semiautomated quantitative morphometry measurements and vertebral fracture assessment using lateral scout views from computed tomography", Osteoporos Int, 22, pp.2677~2688 (2011)
23. Alqahtani FF, "Diagnosis of osteoporotic vertebral fractures in children", Pediatr Radiol, 49, pp.283~296 (2019)
24. Levine MA, "Assessing bone health in children and adolescents", Indian J Endocrinol Metab, 16(Suppl 2), pp.S205~S212 (2012)
25. Stagi S, "Peripheral quantitative computed tomography (pQCT) for the assessment of bone strength in most of bone affecting conditions in developmental age: a review", Ital J Pediatr, 42, pp.88~ (2016)
26. Zemel BS, "Quantitative computed tomography and computed tomography in children", Curr Osteoporos Rep, 9, pp.284~290 (2011)
27. Fewtrell MS, "Bone densitometry in children assessed by dual x ray absorptiometry : uses and pitfalls", Arch Dis Child, 88, pp.795~798 (2003)
28. Shaw N, "Bone density in children : what are we measuring", Arch Dis Child, 104, pp.1108~1111 (2019)
29. Adams JE, "Bone densitometry in children", Semin Musculoskelet Radiol, 20, pp.254~268 (2016)
30. Adesina OO, "Height-corrected low bone density associates with severe outcomes in sickle cell disease : SCCRIP cohort study results", Blood Adv, 3, pp.1476~1488 (2019)
31. Lim JS, "Bone mineral density according to age, bone age, and pubertal stages in korean children and adolescents", J Clin Densitom, 13, pp.68~76 (2010)
32. Orgel E, "Early injury to cortical and cancellous bone from induction chemotherapy for adolescents and young adults treated for acute lymphoblastic leukemia", Bone, 85, pp.131~137 (2016)
33. Pufall MA, "Glucocorticoids and cancer", Adv Exp Med Biol, 872, pp.315~333 (2015)
34. Inaba H, "Glucocorticoid use in acute lymphoblastic leukaemia", Lancet Oncol, 11, pp.1096~1106 (2010)
35. Cushing H, "The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932", Obes Res, 2, pp.486~508 (1994)
36. Akeno N, "Regulation of vitamin D-1alpha-hydroxylase and-24-hydroxylase expression by dexamethasone in mouse kidney", J Endocrinol, 164, pp.339~348 (2000)
37. O'Brien CA, "Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength", Endocrinology, 145, pp.1835~1841 (2004)
38. Jia D, "Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density", Endocrinology, 147, pp.5592~5599 (2006)
39. Tack LJ, "Effects of glucocorticoids on bone : what we can learn from pediatric endogenous Cushing's syndrome", Horm Metab Res, 48, pp.764~770 (2016)
40. Hansen KE, "A systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children", Semin Arthritis Rheum, 44, pp.47~54 (2014)
41. Briot K, "Glucocorticoid-induced osteoporosis", RMD Open, 1, pp.e000014~ (2015)
42. Ward LM, "Osteoporosis due to glucocorticoid use in children with chronic illness", Horm Res, 64, pp.209~221 (2005)
43. Wilson CL, "Bone mineral density deficits and fractures in survivors of childhood cancer", Curr Osteoporos Rep, 11, pp.329~337 (2013)
44. Lentle B, "The radiology of vertebral fractures in childhood osteoporosis related to glucocorticoid administration", J Clin Densitom, 19, pp.81~88 (2016)
45. te Winkel ML, "Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9protocol", Bone, 59, pp.223~228 (2014)
46. Ma J, "Impact of vertebral fractures and glucocorticoid exposure on height deficits in children during treatment of leukemia", J Clin Endocrinol Metab, 104, pp.213~222 (2019)
47. Tian H, "Understanding the mechanisms of action of methotrexate : implications for the treatment of rheumatoid arthritis", Bull NYU Hosp Jt Dis, 65, pp.168~173 (2007)
48. Crofton PM, "Bone turnover and growth during and after continuing chemotherapy in children with acute lymphoblastic leukemia", Pediatr Res, 48, pp.490~496 (2000)
49. Atkinson SA, "Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia", J Pediatr, 114, pp.793~800 (1989)
50. Egler RA, "L-asparaginase in the treatment of patients with acute lymphoblastic leukemia", J Pharmacol Pharmacother, 7, pp.62~71 (2016)
51. Liu C, "Asparaginase potentiates glucocorticoidinduced osteonecrosis in a mouse model", PLoS One, 11, pp.e0151433~ (2016)
52. Nissinen TA, "Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes", Sci Rep, 6, pp.32695~ (2016)
53. Davies JH, "Effects of chemotherapeutic agents on the function of primary human osteoblast-like cells derived from children", J Clin Endocrinol Metab, 88, pp.6088~6097 (2003)
54. 강민재, "Bone mineral density deficits in childhood cancer survivors: Pathophysiology, prevalence, screening, and management", Clinical and Experimental Pediatrics, 56(2), pp.60~67 (2013), 대한소아청소년과학회
55. Gilsanz V, "Osteoporosis after cranial irradiation for acute lymphoblastic leukemia", The Journal of Pediatrics, 117, pp.238~244 (1990)
56. Nysom K, "Bone mass after treatment for acute lymphoblastic leukemia in childhood", J Clin Oncol, 16, pp.3752~3760 (1998)
57. Kaste SC, "Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development", Leukemia, 15, pp.728~734 (2001)
58. Cox CL, "Modifying bone mineral density, physical function, and quality of life in children with acute lymphoblastic leukemia", Pediatr Blood Cancer, 65, pp.e26929~ (2018)
59. Ward LM, "Bone morbidity and recovery in children with acute lymphoblastic leukemia: results of a six-year prospective cohort study", J Bone Miner Res, 33, pp.1435~1443 (2018)
60. Vitanza NA, "The progression of bone mineral density abnormalities after chemotherapy for childhood acute lymphoblastic leukemia", J Pediatr Hematol Oncol, 37, pp.356~361 (2015)
61. Mostoufi-Moab S, "Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation", J Clin Endocrinol Metab, 97, pp.3584~3592 (2012)
62. von Scheven E, "Glucocorticoidassociated osteoporosis in chronic inflammatory diseases : epidemiology, mechanisms, diagnosis, and treatment", Curr Osteoporos Rep, 12, pp.289~299 (2014)
63. Soyka LA, "Clinical review 117 : Hormonal determinants and disorders of peak bone mass in children", J Clin Endocrinol Metab, 85, pp.3951~3963 (2000)
64. Grover M, "Osteoporosis in children with chronic illnesses : diagnosis, monitoring, and treatment", Curr Osteoporos Rep, 15, pp.271~282 (2017)
65. Kaste SC, "Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL)", Pediatr Blood Cancer, 61, pp.885~893 (2014)
66. Jayasena A, "Treatment of glucocorticoid-induced low bone mineral density in children: a systematic review", Int J Rheum Dis, 18, pp.287~293 (2015)
67. Wagner CL, "Prevention of rickets and vitamin D deficiency in infants, children, and adolescents", Pediatrics, 122, pp.1142~1152 (2008)
68. Greer FR, "Optimizing bone health and calcium intakes of infants, children, and adolescents", Pediatrics, 117, pp.578~585 (2006)
69. Sunyecz JA, "The use of calcium and vitamin D in the management of osteoporosis", Ther Clin Risk Manag, 4, pp.827~836 (2008)
70. Saraff V, "Endocrinology and adolescence : osteoporosis in children : diagnosis and management", Eur J Endocrinol, 173, pp.R185~R197 (2015)
71. Cheung MS, "Drugs used in paediatric bone and calcium disorders", Endocr Dev, 28, pp.277~290 (2015)
72. Simioni C, "Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments", Oncotarget, 9, pp.17199~17209 (2018)
73. Lucia A, "Intrahospital supervised exercise training : a complementary tool in the therapeutic armamentarium against childhood leukemia", Leukemia, 19, pp.1334~1337 (2005)

관련 논문AI추천